|
|
|
|
|
(State or other jurisdiction
of incorporation) |
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification) |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
|
|
|
|
Votes
|
Votes
|
Broker
|
||||||
Director Nominee
|
For
|
Against
|
Abstentions
|
Non-Votes
|
||||
Gerald Lieberman
|
11,240,840
|
71,066
|
14,956
|
0
|
||||
Gerald Ostrov
|
11,240,682
|
71,214
|
14,966
|
0
|
||||
Sean Ellis
|
11,238,128
|
73,783
|
14,951
|
0
|
Votes
|
Votes
|
Broker
|
||||
For
|
Against
|
Abstentions
|
Non-Votes
|
|||
10,949,978
|
357,024
|
19,860
|
0
|
Votes
|
Votes
|
Broker
|
||||
For
|
Against
|
Abstentions
|
Non-Votes
|
|||
10,713,933
|
253,951
|
358,978
|
0
|
Votes
|
Votes
|
Broker
|
||||
For
|
Against
|
Abstentions
|
Non-Votes
|
|||
11,060,170
|
245,916
|
20,776
|
0
|
Votes
|
Votes
|
Broker
|
||||
For
|
Against
|
Abstentions
|
Non-Votes
|
|||
11,282,995
|
33,579
|
10,288
|
0
|
ENTERA BIO LTD.
|
||
Date: September 13, 2023
|
By:
|
/s/ Miranda Toledano
|
Name: Miranda Toledano
Title: Chief Executive Officer
|